共 6 条
[1]
[2]
Response-Guided Neoadjuvant Chemotherapy for Breast Cancer[J] Gunter von Minckwitz;Jens Uwe Blohmer;Serban Dan Costa;Carsten Denkert;Holger Eidtmann;Wolfgang Eiermann;Bernd Gerber;Claus Hanusch;J?rn Hilfrich;Jens Huober;Christian Jackisch;Manfred Kaufmann;Sherko Kümmel;Stefan Paepke;Andreas Schneeweiss;Michael Untch;Dirk Michael Zahm;Keyur Mehta;Sibylle Loibl Journal of Clinical Oncology 2013,
[3]
Neoadjuvant Chemotherapy and Targeted Therapy in Breast Cancer: Past; Present; and Future[J] Simon P. Gampenrieder;Gabriel Rinnerthaler;Richard Greil;James L. Mulshine Journal of Oncology 2013,
[4]
Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy[J] Nehmat Houssami;Petra Macaskill;Gunter von Minckwitz;Michael L. Marinovich;Eleftherios Mamounas European Journal of Cancer 2012,
[5]
Meta-analysis confirms achieving pathological complete response after neoadjuvant chemotherapy predicts favourable prognosis for breast cancer patients[J] Xiangnan Kong;Meena S. Moran;Ning Zhang;Bruce Haffty;Qifeng Yang European Journal of Cancer 2011,
[6]
Pathologic Complete Response With Six Compared With Three Cycles of Neoadjuvant Epirubicin Plus Docetaxel and Granulocyte Colony-Stimulating Factor in Operable Breast Cancer: Results of ABCSG-14 Günther G. Steger;Arik Galid;Michael Gnant;Brigitte Mlineritsch;Alois Lang;Christoph Tausch;Margaretha Rudas;Richard Greil;Catharina Wenzel;Christian F. Singer;Anton Haid;Sabine Pstlberger;Hellmut Samonigg;Gero Luschin-Ebengreuth;Werner Kwasny;Eduard Klug;Ernst Kubista;Christian Menzel;Raimund Jake; J. C